Amit Goyal, MD | tctmd.com
Amit Goyal, MD, is a structural interventional cardiologist and Director of the CICU at the Dallas VA Medical Center, Editor-in-Chief of US Cardiology Review, and co-founder —with Daniel Ambinder, MD— of CardioNerds.. In the latter capacity, he leads the overarching curriculum and has designed the CardioNerds Clinical Trials Network, CardioNerds Academy, and Medical Journalism programs.
TCT 2024 - TCTMD.com
2024年10月27日 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
TCTMD - tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
TCTMD Login - tctmd.com
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Young Men Who Take Steroids Have Impaired Coronary Flow, …
2024年12月17日 · Young men who use anabolic-androgenic steroids, or those who’ve used them in the past, are more likely to have reduced myocardial flow reserve than those who’ve never taken the drugs, according to Danish data.. The findings, researchers say, suggest that “supraphysiologic doses of testosterone and synthetic steroids could have adverse impacts in coronary microcirculation.”
ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty …
2024年10月29日 · Interventional cardiologists have many tools at their fingertips to address calcified lesions—which are known to be among the most complex—including angioplasty with conventional balloons as well as cutting and scoring balloons, orbital and rotational atherectomy, and lithotripsy. These new data indicate that the simplest—and notably the cheapest—approach might be the most reasonable.
Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK
2024年11月5日 · LAS VEGAS, NV—At 2 years, a drug-eluting resorbable scaffold continues to show sustained patency and safety compared with conventional angioplasty alone in patients with below-the-knee (BTK) chronic limb-threatening ischemia (CLTI), new follow-up data from the LIFE-BTK trial show.
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
2024年8月28日 · The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply.
ESC Congress 2024 - TCTMD.com
2024年8月30日 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Obesity Trends May Be Going in the Right Direction for the First …
2024年12月18日 · For the first time in more than a decade, the prevalence of obesity among adults in the United States appears to be on the decline, according to an analysis of nationwide trends in body mass index (BMI) and obesity.